Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Smith

Showing results (471-480 of 530) with videos related to

Pageof 53
Sort By:
Blood|March 16, 2002
Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trialFrancesco Bertoni, Annarita Conconi, Carlo Capella, et al.
Health Technology Assessment (Winchester, England)|August 5, 2015
A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleedingT Justin Clark, Lee J Middleton, Natalie Am Cooper, et al.
Internal Medicine Journal|December 25, 2024
Can artificial intelligence improve patient educational material readability? A systematic review and narrative synthesisMohamed Nasra, Rimsha Jaffri, Davor Pavlin-Premrl, et al.
Archives of Toxicology|January 1, 2022
Pharmacological inhibition of MERTK induces in vivo retinal degeneration: a multimodal imaging ocular safety assessmentGregory Hamm, Gareth Maglennon, Beth Williamson, et al.
British Journal of Haematology|November 22, 2018
Bortezomib consolidation post-ASCT as frontline therapy for multiple myeloma deepens disease response and MRD-negative rate whilst maintaining QOL and response to re-treatment at relapseOliver C Cohen, Nicholas Counsell, Neil Rabin, et al.
World Neurosurgery|May 19, 2024
The Clinical and Radiological Outcomes of the Multimodal Use of the Woven EndoBridge Device: A Large Multicenter StudyMohamed Nasra, Davor Pavlin-Premrl, Sara Protto, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2010
The identification of novel orally active mGluR5 antagonist GSK2210875Maria Pilla, Michela Andreoli, Michela Tessari, et al.
Molecular Cancer Research : MCR|October 1, 2003
Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitroPaul J Adam, Joanne Berry, Julie A Loader, et al.
The Lancet. Oncology|March 8, 2014
Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trialKirit M Ardeshna, Wendi Qian, Paul Smith, et al.
Nature Medicine|September 19, 2024
Echocardiographic screening for heart failure and optimization of the care pathway for individuals with pacemakers: a randomized controlled trialMaria F Paton, John Gierula, Haqeel A Jamil, et al.
Pageof 53

Showing results (471-480 of 530) with videos related to

Sort By:
Pageof 53
Blood|March 16, 2002
Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trialFrancesco Bertoni, Annarita Conconi, Carlo Capella, et al.
Health Technology Assessment (Winchester, England)|August 5, 2015
A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleedingT Justin Clark, Lee J Middleton, Natalie Am Cooper, et al.
Internal Medicine Journal|December 25, 2024
Can artificial intelligence improve patient educational material readability? A systematic review and narrative synthesisMohamed Nasra, Rimsha Jaffri, Davor Pavlin-Premrl, et al.
Archives of Toxicology|January 1, 2022
Pharmacological inhibition of MERTK induces in vivo retinal degeneration: a multimodal imaging ocular safety assessmentGregory Hamm, Gareth Maglennon, Beth Williamson, et al.
British Journal of Haematology|November 22, 2018
Bortezomib consolidation post-ASCT as frontline therapy for multiple myeloma deepens disease response and MRD-negative rate whilst maintaining QOL and response to re-treatment at relapseOliver C Cohen, Nicholas Counsell, Neil Rabin, et al.
World Neurosurgery|May 19, 2024
The Clinical and Radiological Outcomes of the Multimodal Use of the Woven EndoBridge Device: A Large Multicenter StudyMohamed Nasra, Davor Pavlin-Premrl, Sara Protto, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2010
The identification of novel orally active mGluR5 antagonist GSK2210875Maria Pilla, Michela Andreoli, Michela Tessari, et al.
Molecular Cancer Research : MCR|October 1, 2003
Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitroPaul J Adam, Joanne Berry, Julie A Loader, et al.
The Lancet. Oncology|March 8, 2014
Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trialKirit M Ardeshna, Wendi Qian, Paul Smith, et al.
Nature Medicine|September 19, 2024
Echocardiographic screening for heart failure and optimization of the care pathway for individuals with pacemakers: a randomized controlled trialMaria F Paton, John Gierula, Haqeel A Jamil, et al.
Pageof 53